Valnei Canutti
Valnei Canutti is a hematologist and the Chief Scientific Officer of Pint Pharma, where he emphasizes the importance of innovative therapies in treating hematological disorders. He highlighted the unique pharmacokinetic properties of BESREMi®, an innovative pegylated interferon approved for the treatment of Polycythemia Vera in Brazil.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Venezuela:
Valnei Canutti, hematologist and Chief Scientific Officer of Pint Pharma, highlighted that BESREMi® is an innovative interferon with unique pharmacokinetic properties.
8